FASTING AND CANCER

  1. Autophagy and intermittent Fasting: the connection for Cancer therapy?
  2. Effects of short-term Fasting on Cancer treatment
  3. Fasting and caloric restriction in Cancer prevention and treatment
  4. Fasting and Cancer treatment in humans: A case series report
  5. Fasting and Cancer: molecular mechanisms and clinical application
  6. Fasting blood glucose and Cancer risk in a cohort of more than 140,000 adults in Austria
  7. Fasting blood glucose level and prognosis in non-small cell lung Cancer (NSCLC) patients
  8. Fasting blood glucose levels provide estimate of duration and progression of pancreatic Cancer before diagnosis
  9. Fasting C-peptide levels and death resulting from all causes and breast Cancer: the health, eating, activity, and lifestyle study
  10. Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic Cancer models
  11. Fasting cycles retard growth of tumors and sensitize a range of Cancer cell types to chemotherapy
  12. Fasting glucose is a risk factor for breast Cancer: a prospective study
  13. Fasting inhibits aerobic glycolysis and proliferation in colorectal Cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression
  14. Fasting insulin and outcome in early-stage breast Cancer: results of a prospective cohort study
  15. Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast Cancer in the multicentre randomized phase 2 DIRECT trial
  16. Fasting plasma amino acid levels in Cancer patients
  17. Fasting serum glucose level and Cancer risk in Korean men and women
  18. Fasting to enhance Cancer treatment in models: the next steps
  19. Fasting vs dietary restriction in cellular protection and Cancer treatment: from model organisms to patients
  20. Fasting-mimicking diet and hormone therapy induce breast Cancer regression
  21. Fasting-mimicking diet and markers/risk factors for aging, diabetes, Cancer, and cardiovascular disease
  22. Fibrinogen synthesis is elevated in Fasting Cancer patients with an acute phase response
  23. Glucose flux in relation to energy expenditure in malnourished patients with and without Cancer during periods of Fasting and feeding
  24. Prolonged nightly Fasting and breast Cancer prognosis
  25. Prolonged nightly Fasting and breast Cancer risk: findings from NHANES (2009–2010)
  26. Reduced levels of IGF-I mediate differential protection of normal and Cancer cells in response to Fasting and improve chemotherapeutic index
  27. Resectability of presymptomatic pancreatic Cancer and its relationship to onset of diabetes: a retrospective review of CT scans and Fasting glucose values prior to …
  28. Temporal association of changes in Fasting blood glucose and body mass index with diagnosis of pancreatic Cancer
  29. The effects of short-term Fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian Cancer: a randomized cross-over pilot …
  30. The effects of short-term Fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast Cancer patients: a randomized pilot study
  31. … added value of Fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical Cancer patients receiving neoadjuvant …
  32. … between Fasting blood glucose and tumor embolus in predicting the postoperative prognosis of 4330 Chinese patients with gastrointestinal tract Cancer
  33. … in the glucokinase gene that raises plasma Fasting glucose, rs1799884, is associated with diabetes mellitus and prostate Cancer: findings from a population …
  34. … modified Fasting and the combination with a Fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in Cancer …
  35. … of exercise training on Fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast Cancer …
  36. … of peroxisome proliferator-activated receptor (PPAR) γ Plo12Ala polymorphism as a shared risk marker for both gastric Cancer and impaired Fasting glucose (IFG) in …
  37. … term Fasting and its combination with a Fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in Cancer …
  38. … -term Fasting and the combination with a Fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in Cancer …
  39. … Fasting Abbreviation with Whey Protein Reduces the Occurrence of Postoperative Complications in Patients With Head and Neck Cancer: A Randomized Clinical …
  40. … Fasting blood glucose predicts a poor prognosis in patients with esophageal squamous cell carcinoma: the Fujian prospective investigation of Cancer(FIESTA …
  41. 146P Safety and metabolic effects of Fasting-mimicking diet in breast Cancer patients
  42. A Complementary Care Study Combining Flaxseed Oil, Caffeine, Fasting, and Exercise in Women Diagnosed with Advanced Ovarian Cancer: Findings from a Case …
  43. A linear dose-response relationship between Fasting plasma glucose and colorectal Cancer risk: Systematic review and meta-analysis
  44. A review of Fasting effects on the response of Cancer to chemotherapy
  45. A Fasting-mimicking diet and vitamin C: turning anti-aging strategies against Cancer
  46. Abstract B022: Metabolic and immunologic effects of the Fastingmimicking diet in Cancer patients
  47. Abstract C107:[Advocate Abstract] Intermittent Fasting for Cancer patients
  48. Adiposity and estrogen receptor‐positive, postmenopausal breast Cancer risk: Quantification of the mediating effects of Fasting insulin and free estradiol
  49. Annual Fasting plasma glucose variation increases risk of Cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes Study
  50. Annual Fasting; the early calories restriction for Cancer prevention
  51. Association between Fasting blood glucose levels at admission and overall survival of patients with pancreatic Cancer
  52. Association between Fasting serum glucose levels and incidence of colorectal Cancer in Korean men: the Korean Cancer Prevention Study-II
  53. Association of Fasting serum insulin and Cancer mortality in a healthy population–28-year follow-up of the French TELECOM Study
  54. Author Correction: Fasting-mimicking diet and hormone therapy induce breast Cancer regression
  55. Body mass index and impaired Fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal Cancer treatment
  56. Cardiopulmonary fitness, adiponectin, chemerin associated Fasting insulin level in colorectal Cancer patients
  57. Cigarette smoking, elevated Fasting serum glucose, and risk of pancreatic Cancer in Korean men
  58. Comparison of the pharmacokinetics of erlotinib administered in complete Fasting and 2 h after a meal in patients with lung Cancer
  59. Comparison of total N-nitrosamides in Fasting gastric juice from subjects in high and low risk areas for gastric Cancer
  60. Could intermittent energy restriction and intermittent Fasting reduce rates of Cancer in obese, overweight, and normal-weight subjects? A summary of evidence
  61. Detection of the differentially expressed gene IGF-binding protein-related protein-1 and analysis of its relationship to Fasting glucose in Chinese colorectal Cancer…
  62. Diet and Chemotherapy: The Effects of Fasting and Ketogenic Diet on Cancer Treatment
  63. Does Fasting during Ramadan trigger non-adherence to oral hormonal therapy in breast Cancer patients?
  64. Effect of home-based exercise intervention on Fasting insulin and adipocytokines in colorectal Cancer survivors: a randomized controlled trial
  65. Effect of intermittent Fasting on prostate Cancer tumor growth in a mouse model
  66. Effect of intermittent Fasting with or without caloric restriction on prostate Cancer growth and survival in SCID mice
  67. Effect of Cancer and Fasting on oxidation of labeled acetate, glucose and glycine to C14O2
  68. Effects of dietary supplementation with medicinal fungus in Fasting glycemia levels of patients with colorectal Cancer: a randomized, double-blind, placebo …
  69. Effects of Fasting on 18F-DCFPyL uptake in prostate Cancer lesions and tissues with known high physiologic uptake
  70. Effects of Fasting on the immune system function and its positive effects on the chemotherapy of various types of Cancer
  71. Elevated Fasting blood glucose is associated with increased risk of breast Cancer: outcome of case-control study conducted in Karachi, Pakistan
  72. Energy and caloric restriction, and Fasting and Cancer: a narrative review
  73. Enhanced therapeutic efficacy in Cancer patients by short-term Fasting: the autophagy connection
  74. Fasting among Muslim Cancer patients during the holy month of Ramadan
  75. Fasting and Glucose-Stimulated Changes in Plasma Glucagon in Pancreatic Cancer: Potential Biomarkers for Detection?
  76. Fasting and weight‐loss restrictive diet practices among 2,700 Cancer survivors: results from the NutriNet‐Santé cohort
  77. Fasting and Cancer treatment: A case series
  78. Fasting blood glucose and lipid profile alterations following twelve-month androgen deprivation therapy in men with prostate Cancer
  79. Fasting blood glucose and long-term prognosis of non-metastatic breast Cancer: a cohort study
  80. Fasting blood glucose and risk of prostate Cancer: A systematic review and meta-analysis of dose-response
  81. Fasting blood glucose level in locally advanced non-small cell lung Cancer: a new prognostic factor?
  82. Fasting blood glucose levels and prognosis in patients with non-small-cell lung Cancer: a prospective cohort study in China
  83. Fasting Blood Glucose, Cholesterol, and Risk of Primary Liver Cancer: The Kailuan Study
  84. Fasting blood glucose, glycaemic control and prostate Cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
  85. Fasting but not casual blood glucose is associated with pancreatic Cancer mortality in Japanese: EPOCH-JAPAN
  86. Fasting glucose and body mass index as predictors of activity in breast Cancer patients treated with everolimus-exemestane: The EverExt study
  87. Fasting glucose and risk of colorectal Cancer in the Korean Multi-center Cancer Cohort
  88. Fasting glucose and treatment outcome in breast and colorectal Cancer patients treated with targeted agents: results from a historic cohort
  89. Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon Cancer models
  90. Fasting inhibits colorectal Cancer growth by reducing M2 polarization of tumor-associated macrophages
  91. Fasting inhibits hepatic stellate cells activation and potentiates anti‐Cancer activity of Sorafenib in hepatocellular Cancer cells
  92. Fasting inhibits human Cancer progression via the epithelial-mesenchymal transition process: Important evidence unraveled
  93. Fasting insulin and risk of Cancer related mortality in non-diabetic adults: A dose-response meta-analysis of cohort studies
  94. Fasting levels of high-sensitivity growth hormone predict cardiovascular morbidity and mortality: The Malmö Diet and Cancer study
  95. Fasting plasma carotenoids concentrations in Crohn’s and pancreatic Cancer patients compared to control subjects
  96. Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung Cancer treated with concurrent …
  97. Fasting Plasma Glucose Variability and Gastric Cancer Risk in Individuals Without Diabetes Mellitus: A Nationwide Population-Based Cohort Study
  98. Fasting plus tyrosine kinase inhibitors in Cancer
  99. Fasting proinsulin levels are significantly associated with 20 year Cancer mortality rates. The Hoorn Study
  100. Fasting reduces intestinal radiotoxicity, enabling dose-escalated radiation therapy for pancreatic Cancer
  101. Fasting serum glucose and subsequent liver Cancer risk in a Korean prospective cohort
  102. Fasting serum glucose level and gastric Cancer risk in a nested case-control study
  103. Fasting Serum Glucose Level and Cancer Risk in Korean Men and Women—Reply
  104. Fasting serum glucose, thyroid‐stimulating hormone, and thyroid hormones and risk of papillary thyroid Cancer: A case‐control study
  105. Fasting serum levels of potassium and sodium in relation to long-term risk of Cancer in healthy men
  106. Fasting, fats, and physics: combining ketogenic and radiation therapy against Cancer
  107. Fasting: starving Cancer
  108. Fasting-induced differential stress sensitization in Cancer treatment
  109. Fasting-mimicking diet plus chemotherapy in breast Cancer treatment
  110. Feasibility of” no tube no Fasting” therapy in thoracolaparoscopic oesophagectomy for patients with oesophageal Cancer
  111. GLUT 1 receptor expression and circulating levels of Fasting glucose in high grade serous ovarian Cancer
  112. High Fasting blood glucose and obesity significantly and independently increase risk of breast Cancer death in hormone receptor-positive disease
  113. Impact of Fasting plasma glucose levels on gastric Cancer incidence in a general Japanese population: the Hisayama study
  114. Impaired Fasting glucose, single-nucleotide polymorphisms, and risk for colorectal Cancer in Koreans
  115. Increased Fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel Cancer
  116. Influence of pre-operative oral carbohydrate loading vs. standard Fasting on tumor proliferation and clinical outcome in breast Cancer patients─ a randomized …
  117. Is perioperative Fasting associated with complications, length of hospital stay and mortality among gastric and colorectal Cancer patients? A cohort study
  118. JOURNAL CLUB: Preparative Fasting for contrast-enhanced ct in a Cancer center: a new approach
  119. Liver Cancer is induced by a subnecrogenic dose of DENA when associated with Fasting/refeeding: role of glutathione-transferase and lipid peroxidation
  120. Long-term patterns of Fasting blood glucose levels and pancreatic Cancer incidence
  121. Medical synopsis: Nightly Fasting may assist breast Cancer patients and other people with Cancer
  122. Mendelian Randomization Analysis Identifies Body Mass Index and Fasting Insulin as Potential Causal Risk Factors for Pancreatic Cancer Risk
  123. Metabolic regulation of Sirtuins upon Fasting and the implication for Cancer
  124. Metformin induces a Fasting-and antifolate-mimicking modification of systemic host metabolism in breast Cancer patients
  125. Obesity, weight change, Fasting insulin, proinsulin, C-peptide, and insulin-like growth factor-1 levels in women with and without breast Cancer: the Rancho Bernardo …
  126. Overnight Fasting before lapatinib administration to breast Cancer patients leads to reduced toxicity compared with nighttime dosing: a retrospective cohort study from a …
  127. p53 status as effect modifier of the association between pre-treatment Fasting glucose and breast Cancer outcomes in non diabetic, HER2 positive patients …
  128. Periodic Fasting mimicking diet delays Cancer development and progression
  129. Postoperative Fasting Blood Glucose Predicts Prognosis in Stage I-III Colorectal Cancer Patients Undergoing Resection
  130. Potentiation of crizotinib activity by Fasting cycles in an ALK+ lung Cancer
  131. Predictors of Fasting serum insulin and glucose and the risk of pancreatic Cancer in smokers
  132. Quality of life and illness perceptions in patients with breast Cancer using a Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy in the phase 2 …
  133. Ramadan Fasting and patients with Cancer: state-of-the-art and future prospects
  134. Retrospective analysis of Fasting glucose levels in colorectal Cancer patients [J]
  135. Roles of caloric restriction, ketogenic diet and intermittent Fasting during initiation, progression and metastasis of Cancer in animal models: a systematic review …
  136. Safety and Feasibility of Intermittent Fasting During Chemotherapy for Breast Cancer: A Review of the Literature
  137. Short-term Fasting accompanying chemotherapy as a supportive therapy in gynecological Cancer: protocol for a multicenter randomized controlled clinical trial
  138. Significance of low-carbohydrate diets and Fasting in patients with Cancer
  139. The association between Fasting blood glucose and the risk of primary liver Cancer in Chinese males: a population-based prospective study
  140. The association between Fasting blood glucose trajectory and Cancer risk in Chinese population without diabetes
  141. The behavior of Turkish Cancer patients in Fasting during the holy month of Ramadan
  142. The Effect of Caloric Restriction and Fasting on Cancer
  143. The effect of intermittent Fasting on Cancer prevention: a systematic review
  144. The effect of Fasting on the important molecular mechanisms related to Cancer treatment
  145. The effects of diabetes and Fasting plasma glucose on treatment of breast Cancer with neoadjuvant chemotherapy
  146. The incremental risk of pancreatic Cancer according to Fasting glucose levels: Nationwide population-based cohort study
  147. The prognostic influence of body mass index, resting energy expenditure and Fasting blood glucose on postoperative patients with esophageal Cancer
  148. The risk trajectory between preoperative Fasting glucose and common digestive tract Cancer-specific mortality in the FIESTA cohort involving 6865 Chinese …
  149. Tumour necrosis factor-alpha, interleukin-6, and Fasting serum insulin correlate with clinical outcome in metastatic breast Cancer patients treated with chemotherapy
  150. Variation in Fasting and non-Fasting serum enterolactone concentrations in women of the Malmö diet and Cancer cohort